{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T08:42:24Z","timestamp":1761986544099,"version":"3.37.3"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,8,2]],"date-time":"2020-08-02T00:00:00Z","timestamp":1596326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,2]],"date-time":"2020-08-02T00:00:00Z","timestamp":1596326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004006","name":"Bilimsel Ara\u015ftirma Projeleri Birimi, Istanbul \u00dcniversitesi","doi-asserted-by":"publisher","award":["36852"],"award-info":[{"award-number":["36852"]}],"id":[{"id":"10.13039\/501100004006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s00296-020-04663-9","type":"journal-article","created":{"date-parts":[[2020,8,2]],"date-time":"2020-08-02T05:02:20Z","timestamp":1596344540000},"page":"1613-1623","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Does immunosuppressive treatment entail an additional risk for children with rheumatic diseases? A survey-based study in the era of COVID-19"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0101-9585","authenticated-orcid":false,"given":"Oya","family":"Koker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9950-2489","authenticated-orcid":false,"given":"Fatma Gul","family":"Demirkan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7490-7076","authenticated-orcid":false,"given":"Gulsah","family":"Kayaalp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1667-2480","authenticated-orcid":false,"given":"Figen","family":"Cakmak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1386-4575","authenticated-orcid":false,"given":"Ayse","family":"Tanatar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3232-0055","authenticated-orcid":false,"given":"Serife Gul","family":"Karadag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9186-3068","authenticated-orcid":false,"given":"Hafize Emine","family":"Sonmez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3740-6552","authenticated-orcid":false,"given":"Rukiye","family":"Omeroglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3594-7387","authenticated-orcid":false,"given":"Nuray","family":"Aktay Ayaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,2]]},"reference":[{"key":"4663_CR1","unstructured":"World Health Organization (WHO).org [Internet]. Coronavirus disease (COVID-19) outbreak situation 2020.Available from: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019 Accessed 25 May 2020"},{"issue":"1","key":"4663_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40779-020-00240-0","volume":"7","author":"YR Guo","year":"2020","unstructured":"Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, Tan KS, Wang DY, Yan Y (2020) The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak \u2013 an update on the status. Military Med Res 7(1):11. https:\/\/doi.org\/10.1186\/s40779-020-00240-0","journal-title":"Military Med Res"},{"issue":"2","key":"4663_CR3","doi-asserted-by":"crossref","first-page":"337","DOI":"10.55563\/clinexprheumatol\/xcdary","volume":"38","author":"P Sarzi-Puttini","year":"2020","unstructured":"Sarzi-Puttini P, Giorgi V, Sirotti S, Marotto D, Ardizzone S, Rizzardini G, Antinori S, Galli M (2020) COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? Clin Exp Rheumatol 38(2):337\u2013342","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"4663_CR4","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nrd.2015.37","volume":"15","author":"A Zumla","year":"2016","unstructured":"Zumla A, Chan JF, Azhar EI, Hui DS, Yuen KY (2016) Coronaviruses \u2013 drug discovery and therapeutic options. Nat Rev Drug Discovery 15(5):327\u2013347. https:\/\/doi.org\/10.1038\/nrd.2015.37","journal-title":"Nat Rev Drug Discovery"},{"issue":"5","key":"4663_CR5","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3899\/jrheum.200334","volume":"47","author":"RQ Cron","year":"2020","unstructured":"Cron RQ, Chatham WW (2020) The Rheumatologist's Role in COVID-19. J Rheumatol 47(5):639\u2013642. https:\/\/doi.org\/10.3899\/jrheum.200334","journal-title":"J Rheumatol"},{"issue":"3","key":"4663_CR6","first-page":"373","volume":"38","author":"F Ferro","year":"2020","unstructured":"Ferro F, Elefante E, Puxeddu I, Baldini C, Bartoloni E, Barat\u00e8 C, Galimberti S, Talarico R, Mosca M, Bombardieri S (2020) COVID-19: the new challenge for rheumatologists First update. Clin Experim Rheumatol 38(3):373\u2013382","journal-title":"Clin Experim Rheumatol"},{"key":"4663_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102574","author":"P Sarzi-Puttini","year":"2020","unstructured":"Sarzi-Puttini P, Marotto D, Antivalle M, Salaffi F, Atzeni F, Maconi G, Monteleone G, Rizzardini G, Antinori S, Galli M, Ardizzone S (2020) How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion. Autoimmunity Rev. https:\/\/doi.org\/10.1016\/j.autrev.2020.102574","journal-title":"Autoimmunity Rev"},{"key":"4663_CR8","doi-asserted-by":"publisher","DOI":"10.4274\/balkanmedj.galenos.2020.2020.4.43","author":"F Ha\u015flak","year":"2020","unstructured":"Ha\u015flak F, Y\u0131ld\u0131z M, Adrovic A, Barut K, Kasap\u00e7opur \u00d6 (2020) Childhood Rheumatic Diseases and COVID-19 Pandemic: An Intriguing Linkage and a New Horizon. Balkan Med J. https:\/\/doi.org\/10.4274\/balkanmedj.galenos.2020.2020.4.43","journal-title":"Balkan Med J"},{"key":"4663_CR9","doi-asserted-by":"publisher","unstructured":"Mikuls TR, Johnson SR, Fraenkel L, Arasaratnam RJ, Baden LR, Bermas BL, Chatham W, Cohen S, Costenbader K, Gravallese EM, Kalil AC, Weinblatt ME, Winthrop K, Mudano AS, Turner A, Saag KG (2020) American College of Rheumatology Guidance for the Management of Adult Patients with Rheumatic Disease During the COVID-19 Pandemic. Arthrit Rheumatol (Hoboken, NJ). https:\/\/doi.org\/10.1002\/art.41301","DOI":"10.1002\/art.41301"},{"key":"4663_CR10","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.200492","author":"RQ Cron","year":"2020","unstructured":"Cron RQ, Chatham WW (2020) The question of whether to remain on therapy for chronic rheumatic diseases in the setting of the covid-19 pandemic. J Rheumatol. https:\/\/doi.org\/10.3899\/jrheum.200492","journal-title":"J Rheumatol"},{"issue":"6","key":"4663_CR11","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1002\/ppul.24762","volume":"55","author":"Q Shen","year":"2020","unstructured":"Shen Q, Guo W, Guo T, Li J, He W, Ni S, Ouyang X, Liu J, Xie Y, Tan X, Zhou Z, Peng H (2020) Novel coronavirus infection in children outside of Wuhan. China Pediatric Pulmonol 55(6):1424\u20131429. https:\/\/doi.org\/10.1002\/ppul.24762","journal-title":"China Pediatric Pulmonol"},{"key":"4663_CR12","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-0702","author":"Y Dong","year":"2020","unstructured":"Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, Tong S (2020) Epidemiology of COVID-19 Among Children in China. Pediatrics. https:\/\/doi.org\/10.1542\/peds.2020-0702","journal-title":"Pediatrics"},{"key":"4663_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(20)30198-5","author":"H Qiu","year":"2020","unstructured":"Qiu H, Wu J, Hong L, Luo Y, Song Q, Chen D (2020) Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study. Lancet Infect Dis. https:\/\/doi.org\/10.1016\/s1473-3099(20)30198-5","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"4663_CR14","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1002\/ppul.24734","volume":"55","author":"Y Li","year":"2020","unstructured":"Li Y, Guo F, Cao Y, Li L, Guo Y (2020) Insight into COVID-2019 for pediatricians. Pediatr Pulmonol 55(5):E1\u2013e4. https:\/\/doi.org\/10.1002\/ppul.24734","journal-title":"Pediatr Pulmonol"},{"issue":"8","key":"4663_CR15","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s00296-020-04612-6","volume":"40","author":"ED Batu","year":"2020","unstructured":"Batu ED, \u00d6zen S (2020) Implications of COVID-19 in pediatric rheumatology. Rheumatol Int 40(8):1193\u20131213. https:\/\/doi.org\/10.1007\/s00296-020-04612-6","journal-title":"Rheumatol Int"},{"key":"4663_CR16","doi-asserted-by":"publisher","first-page":"108420","DOI":"10.1016\/j.clim.2020.108420","volume":"214","author":"CM Hedrich","year":"2020","unstructured":"Hedrich CM (2020) COVID-19 \u2013 Considerations for the paediatric rheumatologist. Clin Immunol (Orlando, Fla) 214:108420. https:\/\/doi.org\/10.1016\/j.clim.2020.108420","journal-title":"Clin Immunol (Orlando, Fla)"},{"issue":"6","key":"4663_CR17","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1093\/rheumatology\/keaa194","volume":"59","author":"B Lucchino","year":"2020","unstructured":"Lucchino B, Di Franco M, Conti F (2020) COVID-19: an unexpected indication for anti-rheumatic therapies? Rheumatology (Oxford, England) 59(6):1200\u20131203. https:\/\/doi.org\/10.1093\/rheumatology\/keaa194","journal-title":"Rheumatology (Oxford, England)"},{"issue":"2","key":"4663_CR18","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s11596-020-2172-6","volume":"40","author":"F Zheng","year":"2020","unstructured":"Zheng F, Liao C, Fan QH, Chen HB, Zhao XG, Xie ZG, Li XL, Chen CX, Lu XX, Liu ZS, Lu W, Chen CB, Jiao R, Zhang AM, Wang JT, Ding XW, Zeng YG, Cheng LP, Huang QF, Wu J, Luo XC, Wang ZJ, Zhong YY, Bai Y, Wu XY, Jin RM (2020) Clinical Characteristics of Children with Coronavirus Disease 2019 in Hubei China. Curr Med Sci 40(2):275\u2013280. https:\/\/doi.org\/10.1007\/s11596-020-2172-6","journal-title":"Curr Med Sci"},{"key":"4663_CR19","doi-asserted-by":"publisher","unstructured":"Chen F, Liu ZS, Zhang FR, Xiong RH, Chen Y, Cheng XF, Wang WY, Ren J (2020) [First case of severe childhood novel coronavirus pneumonia in China. Zhonghua er ke za zhi = Chinese J Pediatrics 58 (3):179\u2013182. https:\/\/doi.org\/10.3760\/cma.j.issn.0578-1310.2020.03.003","DOI":"10.3760\/cma.j.issn.0578-1310.2020.03.003"},{"issue":"4","key":"4663_CR20","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3345\/cep.2020.00535","volume":"63","author":"SH Choi","year":"2020","unstructured":"Choi SH, Kim HW, Kang JM, Kim DH, Cho EY (2020) Epidemiology and clinical features of coronavirus disease 2019 in children. Clin Experim Pediatrics 63(4):125\u2013132. https:\/\/doi.org\/10.3345\/cep.2020.00535","journal-title":"Clin Experim Pediatrics"},{"issue":"3","key":"4663_CR21","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.jfma.2020.02.009","volume":"119","author":"Q Cao","year":"2020","unstructured":"Cao Q, Chen YC, Chen CL, Chiu CH (2020) SARS-CoV-2 infection in children: Transmission dynamics and clinical characteristics. J Formosan Med Assoc Taiwan yi zhi 119(3):670\u2013673. https:\/\/doi.org\/10.1016\/j.jfma.2020.02.009","journal-title":"J Formosan Med Assoc Taiwan yi zhi"},{"issue":"5","key":"4663_CR22","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/inf.0000000000002660","volume":"39","author":"P Zimmermann","year":"2020","unstructured":"Zimmermann P, Curtis N (2020) Coronavirus Infections in Children Including COVID-19: An Overview of the Epidemiology, Clinical Features, Diagnosis, Treatment and Prevention Options in Children. Pediatr Infect Dis J 39(5):355\u2013368. https:\/\/doi.org\/10.1097\/inf.0000000000002660","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"4663_CR23","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s10067-018-4367-9","volume":"38","author":"D Aygun","year":"2019","unstructured":"Aygun D, Sahin S, Adrovic A, Barut K, Cokugras H, Camc\u0131oglu Y, Kasapcopur O (2019) The frequency of infections in patients with juvenile idiopathic arthritis on biologic agents: 1-year prospective study. Clin Rheumatol 38(4):1025\u20131030. https:\/\/doi.org\/10.1007\/s10067-018-4367-9","journal-title":"Clin Rheumatol"},{"issue":"1","key":"4663_CR24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12969-020-00422-z","volume":"18","author":"F Licciardi","year":"2020","unstructured":"Licciardi F, Giani T, Baldini L, Favalli EG, Caporali R, Cimaz R (2020) COVID-19 and what pediatric rheumatologists should know: a review from a highly affected country. Pediatric Rheumatol Online J 18(1):35. https:\/\/doi.org\/10.1186\/s12969-020-00422-z","journal-title":"Pediatric Rheumatol Online J"},{"key":"4663_CR25","doi-asserted-by":"publisher","first-page":"102442","DOI":"10.1016\/j.jaut.2020.102442","volume":"109","author":"A Ceribelli","year":"2020","unstructured":"Ceribelli A, Motta F, De Santis M, Ansari AA, Ridgway WM, Gershwin ME, Selmi C (2020) Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy. J Autoimmun 109:102442. https:\/\/doi.org\/10.1016\/j.jaut.2020.102442","journal-title":"J Autoimmun"},{"issue":"2","key":"4663_CR26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.55563\/clinexprheumatol\/r3k9l6","volume":"38","author":"F Ferro","year":"2020","unstructured":"Ferro F, Elefante E, Baldini C, Bartoloni E, Puxeddu I, Talarico R, Mosca M, Bombardieri S (2020) COVID-19: the new challenge for rheumatologists. Clin Exp Rheumatol 38(2):175\u2013180","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"4663_CR27","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1007\/s10067-020-05073-9","volume":"39","author":"DP Misra","year":"2020","unstructured":"Misra DP, Agarwal V, Gasparyan AY, Zimba O (2020) Rheumatologists' perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets. Clin Rheumatol 39(7):2055\u20132062. https:\/\/doi.org\/10.1007\/s10067-020-05073-9","journal-title":"Clin Rheumatol"},{"key":"4663_CR28","unstructured":"European League Against Rheumatism (EULAR).org [Internet]. Guidance for patients COVID-19 outbreak 2020. Available from: https:\/\/www.eular.org\/eular_guidance_for_patientscovid19_outbreak.cfm Accessed 25 May 2020."},{"key":"4663_CR29","unstructured":"Paediatric Rheumatology INternational Trials Organisation (PRINTO).org [Internet]. PRES recommendations in the corona era- COVID-19,2020. Available from: https:\/\/www.printo.it\/pediatric-rheumatology\/ Accessed 25 May 2020"},{"issue":"5","key":"4663_CR30","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1136\/annrheumdis-2020-217424","volume":"79","author":"S Monti","year":"2020","unstructured":"Monti S, Balduzzi S, Delvino P, Bellis E, Quadrelli VS, Montecucco C (2020) Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies. Ann Rheum Dis 79(5):667\u2013668. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217424","journal-title":"Ann Rheum Dis"},{"key":"4663_CR31","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.200483","author":"G Filocamo","year":"2020","unstructured":"Filocamo G, Minoia F, Carbogno S, Costi S, Romano M, Cimaz R (2020) Absence of severe complications from SARS-CoV-2 infection in children with rheumatic diseases treated with biologic drugs. J Rheumat. https:\/\/doi.org\/10.3899\/jrheum.200483","journal-title":"J Rheumat"},{"key":"4663_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217615","author":"EG Favalli","year":"2020","unstructured":"Favalli EG, Ingegnoli F, Cimaz R, Caporali R (2020) What is the true incidence of COVID-19 in patients with rheumatic diseases? Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217615","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"4663_CR33","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1007\/s00296-020-04613-5","volume":"40","author":"Z Mukusheva","year":"2020","unstructured":"Mukusheva Z, Assylbekova M, Poddighe D (2020) Management of pediatric rheumatic patients in Kazakhstan during the coronavirus disease 2019 (COVID-19) pandemic. Rheumatol Int 40(8):1351\u20131352. https:\/\/doi.org\/10.1007\/s00296-020-04613-5","journal-title":"Rheumatol Int"},{"key":"4663_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-020-04645-x","author":"F Haslak","year":"2020","unstructured":"Haslak F, Yildiz M, Adrovic A, Sahin S, Koker O, Aliyeva A, Barut K, Kasapcopur O (2020) Management of childhood-onset autoinflammatory diseases during the COVID-19 pandemic. Rheumatol Int. https:\/\/doi.org\/10.1007\/s00296-020-04645-x","journal-title":"Rheumatol Int"},{"issue":"5","key":"4663_CR35","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1002\/ppul.24718","volume":"55","author":"W Xia","year":"2020","unstructured":"Xia W, Shao J, Guo Y, Peng X, Li Z, Hu D (2020) Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults. Pediatr Pulmonol 55(5):1169\u20131174. https:\/\/doi.org\/10.1002\/ppul.24718","journal-title":"Pediatr Pulmonol"},{"issue":"5","key":"4663_CR36","doi-asserted-by":"publisher","first-page":"102523","DOI":"10.1016\/j.autrev.2020.102523","volume":"19","author":"EG Favalli","year":"2020","unstructured":"Favalli EG, Ingegnoli F, De Lucia O, Cincinelli G, Cimaz R, Caporali R (2020) COVID-19 infection and rheumatoid arthritis: Faraway, so close! Autoimmun Rev 19(5):102523. https:\/\/doi.org\/10.1016\/j.autrev.2020.102523","journal-title":"Autoimmun Rev"},{"key":"4663_CR37","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa237","author":"X Yao","year":"2020","unstructured":"Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P, Liu X, Zhao L, Dong E, Song C, Zhan S, Lu R, Li H, Tan W, Liu D (2020) In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clin Infectious Dis. https:\/\/doi.org\/10.1093\/cid\/ciaa237","journal-title":"Clin Infectious Dis"},{"issue":"5","key":"4663_CR38","doi-asserted-by":"publisher","first-page":"105960","DOI":"10.1016\/j.ijantimicag.2020.105960","volume":"55","author":"J Fantini","year":"2020","unstructured":"Fantini J, Di Scala C, Chahinian H, Yahi N (2020) Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection. Int J Antimicrob Agents 55(5):105960. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105960","journal-title":"Int J Antimicrob Agents"},{"key":"4663_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/v10050268","author":"P Roques","year":"2018","unstructured":"Roques P, Thiberville SD, Dupuis-Maguiraga L, Lum FM, Labadie K, Martinon F, Gras G, Lebon P, Ng LFP, de Lamballerie X, Le Grand R (2018) Paradoxical Effect of Chloroquine Treatment in Enhancing Chikungunya Virus Infection. Viruses. https:\/\/doi.org\/10.3390\/v10050268","journal-title":"Viruses"},{"key":"4663_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102468","author":"C Perricone","year":"2020","unstructured":"Perricone C, Triggianese P, Bartoloni E, Cafaro G, Bonifacio AF, Bursi R, Perricone R, Gerli R (2020) The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19. J Autoimmunity. https:\/\/doi.org\/10.1016\/j.jaut.2020.102468","journal-title":"J Autoimmunity"},{"key":"4663_CR41","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.200369","author":"R Scuccimarri","year":"2020","unstructured":"Scuccimarri R, Sutton E, Fitzcharles MA (2020) Hydroxychloroquine: A Potential Ethical Dilemma for Rheumatologists during the COVID-19 Pandemic. J Rheumatol. https:\/\/doi.org\/10.3899\/jrheum.200369","journal-title":"J Rheumatol"},{"key":"4663_CR42","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-020-00395-2","author":"S Costi","year":"2020","unstructured":"Costi S, Caporali R, Cimaz R (2020) Dealing with COVID-19 in a Pediatric Rheumatology Unit in Italy. Paediatric Drugs. https:\/\/doi.org\/10.1007\/s40272-020-00395-2","journal-title":"Paediatric Drugs"},{"key":"4663_CR43","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13176","author":"JT Silva","year":"2018","unstructured":"Silva JT, P\u00e9rez-Gonz\u00e1lez V, Lopez-Medrano F, Alonso-Moralejo R, Fern\u00e1ndez-Ruiz M, San-Juan R, Bra\u00f1as P, Folgueira MD, Aguado JM, de Pablo-Gafas A (2018) Experience with leflunomide as treatment and as secondary prophylaxis for cytomegalovirus infection in lung transplant recipients: A case series and review of the literature. Clin Transplan. https:\/\/doi.org\/10.1111\/ctr.13176","journal-title":"Clin Transplan"},{"issue":"5","key":"4663_CR44","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s00296-020-04570-z","volume":"40","author":"T Georgiev","year":"2020","unstructured":"Georgiev T (2020) Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs. Rheumatol Int 40(5):825\u2013826. https:\/\/doi.org\/10.1007\/s00296-020-04570-z","journal-title":"Rheumatol Int"},{"issue":"10229","key":"4663_CR45","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/s0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ (2020) COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet (London, England) 395(10229):1033\u20131034. https:\/\/doi.org\/10.1016\/s0140-6736(20)30628-0","journal-title":"Lancet (London, England)"},{"issue":"1","key":"4663_CR46","doi-asserted-by":"publisher","first-page":"8543","DOI":"10.4081\/idr.2020.8543","volume":"12","author":"E Nicastri","year":"2020","unstructured":"Nicastri E, Petrosillo N, Bartoli TA, Lepore L, Mondi A, Palmieri F, D'Offizi G, Marchioni L, Murachelli S, Ippolito G, Antinori A (2020) National Institute for the Infectious Diseases \"L Spallanzani\", IRCCS Recommendations for COVID-19 clinical management. Infectious Dis Rep 12(1):8543. https:\/\/doi.org\/10.4081\/idr.2020.8543","journal-title":"Infectious Dis Rep"},{"key":"4663_CR47","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217681","author":"E Conticini","year":"2020","unstructured":"Conticini E, Bargagli E, Bardelli M, Rana GD, Baldi C, Cameli P, Gentileschi S, Bennett D, Falsetti P, Lanzarone N, Bellisai F, Barreca C, D'Alessandro R, Cantarini L, Frediani B (2020) COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217681","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"4663_CR48","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.cell.2020.04.042","volume":"181","author":"MG Netea","year":"2020","unstructured":"Netea MG, Giamarellos-Bourboulis EJ, Dom\u00ednguez-Andr\u00e9s J, Curtis N, van Crevel R, van de Veerdonk FL, Bonten M (2020) Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection. Cell 181(5):969\u2013977. https:\/\/doi.org\/10.1016\/j.cell.2020.04.042","journal-title":"Cell"},{"issue":"6","key":"4663_CR49","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41577-020-0337-y","volume":"20","author":"LAJ O'Neill","year":"2020","unstructured":"O'Neill LAJ, Netea MG (2020) BCG-induced trained immunity: can it offer protection against COVID-19? Nat Rev Immunol 20(6):335\u2013337. https:\/\/doi.org\/10.1038\/s41577-020-0337-y","journal-title":"Nat Rev Immunol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04663-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-020-04663-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04663-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,5]],"date-time":"2022-11-05T12:20:25Z","timestamp":1667650825000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-020-04663-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,2]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["4663"],"URL":"https:\/\/doi.org\/10.1007\/s00296-020-04663-9","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"type":"print","value":"0172-8172"},{"type":"electronic","value":"1437-160X"}],"subject":[],"published":{"date-parts":[[2020,8,2]]},"assertion":[{"value":"8 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standard"}},{"value":"Author O.K, Author FG.D, Author G.K, Author F.C, Author A.T, Author SG.K, Author HE.S, Author R.O and Author N.AA declare that they have no conflict of interest including specific financial interests, relationships and\/or affiliations relevant to the subject matter or materials. All authors declare that they have no relationship with pharm agencies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Approval was obtained for the study from the Ethics Committee of Istanbul University, Istanbul Faculty of Medicine (approved: May 2020-62254). Informed consent was obtained from the legally authorized representatives of our patients. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors. Our article has been shared on the \u2018research square platform\u2019 as a preprint ().","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}